Discovery of molecular glues for modulating MHC presentation of cancer neoantigens
Antigen presentation by MHC class I molecules is essential for cancer immunosurveillance, but many cancer-specific antigens fail to form complexes with Class I MHC and are poorly presented on the cell surface. In this study, we present a chemical strategy to overcome this limitation by identifying peptide MHC glues (PMGs) that promote the formation of peptide-MHC complexes with otherwise unpresentable cancer antigens. Crystal structures of these complexes show that our compounds stabilize antigen-MHC binding by making simultaneous interactions with the MHC protein and the antigen peptides. These findings reveal a new approach for chemically rewiring Class I MHC antigen presentation and accessing rare cancer antigens for therapeutic targeting.
Authors
- Changhao He (ORCID: https://orcid.org/0000-0001-8181-2104)
- Wenqi Shen (ORCID: https://orcid.org/0000-0002-8657-4931)
- Keelan Z. Guiley (ORCID: https://orcid.org/0000-0002-8149-4262)
- Kevan M. Shokat (ORCID: https://orcid.org/0000-0001-8590-7741)
- Vishal D Lashkari (ORCID: https://orcid.org/0009-0009-5499-6599)
- Ziyang Zhang (ORCID: https://orcid.org/0000-0003-0541-7211)
- Peter M. Bruno (ORCID: https://orcid.org/0000-0003-3383-0118)
- Julia Hernandez (ORCID: https://orcid.org/0009-0009-3948-8895)
Institutions
- Howard Hughes Medical Institute (US)
- University of California, San Francisco (US)
- Parker Institute for Cancer Immunotherapy (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.64898/2026.11.13.762685
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- preprint